Orlaith Ryan is CTO, Co-Founder, and board member of Shorla Oncology (‘Shorla’), a pharmaceutical company headquartered in Ireland with an office in Cambridge, Massachusetts. Shorla Oncology develops and commercialises innovative oncology drugs solving unmet needs by focusing on indications where existing treatments are limited, in shortage, or inadequate for the target population.
Orlaith is a Chartered scientist and holds an MSc in Regulatory Affairs from the University of Wales, BSc in Applied Biology with Quality Management from Waterford Institute of Technology & a Certificate in Corporate Governance from INSEAD.